These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10923761)

  • 1. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
    Zhu H; Barr GA
    Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
    Zhu H; Barr GA
    Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors.
    Vidal L; Durán R; Faro LF; Campos F; Cervantes RC; Alfonso M
    Toxicology; 2007 Sep; 238(2-3):140-6. PubMed ID: 17624650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.
    Campos F; Alfonso M; Vidal L; Faro LR; Durán R
    Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.
    Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ
    Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
    Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.
    Jones KL; Zhu H; Jenab S; Du T; Inturrisi CE; Barr GA
    Neuropsychopharmacology; 2002 Mar; 26(3):301-10. PubMed ID: 11850145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone's effects on pentylenetetrazole-induced seizure threshold in mice: NMDA/opioid receptors and nitric oxide signaling.
    Kazemi Roodsari S; Bahramnejad E; Rahimi N; Aghaei I; Dehpour AR
    Ann N Y Acad Sci; 2019 Aug; 1449(1):25-35. PubMed ID: 30957236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glutamate receptors and nitric oxide on the effects of glufosinate ammonium, an organophosphate pesticide, on in vivo dopamine release in rat striatum.
    Faro LR; Ferreira Nunes BV; Alfonso M; Ferreira VM; Durán R
    Toxicology; 2013 Sep; 311(3):154-61. PubMed ID: 23810826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.
    Herman BH; Vocci F; Bridge P
    Neuropsychopharmacology; 1995 Dec; 13(4):269-93. PubMed ID: 8747752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nitric oxide synthase inhibitors and molsidomine on the anticonvulsant activity of some antiepileptic drugs.
    Baran L; Siwanowicz J; Przegaliński E
    Pol J Pharmacol; 1997; 49(5):363-8. PubMed ID: 9566037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of NMDA Receptors and Nitric Oxide Synthesis Potentiated Morphine-Induced Anti-Allodynia via Attenuating Pain-Related Amygdala pCREB/CREB Signaling Pathway.
    Tolou-Dabbaghian B; Delphi L; Rezayof A
    J Pain; 2019 Aug; 20(8):885-897. PubMed ID: 30707953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate physical dependence and N-methyl-D-aspartate receptors.
    Noda Y; Nabeshima T
    Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
    Buccafusco JJ; Terry AV; Shuster L
    Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors.
    Faro LR; do Nascimento JL; Alfonso M; Durán R
    Neuropharmacology; 2002 Apr; 42(5):612-8. PubMed ID: 11985818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
    Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
    Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
    Vaupel DB; Kimes AS; London ED
    Neuropsychopharmacology; 1995 Dec; 13(4):315-22. PubMed ID: 8747756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.